Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pearl Bakhru

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Rapamycin-induced enhancement of vaccine efficacy in miceChinnaswamy Jagannath, Pearl Bakhru
The Journal of Clinical Investigation|March 22, 2016
Estrogen turns down "the AIRE"Pearl Bakhru, Maureen A Su
Cellular Immunology|January 4, 2014
BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9Pearl Bakhru, Natalie Sirisaengtaksin, Emily Soudani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
Cutting edge: Nicastrin and related components of γ-secretase generate a peptide epitope facilitating immune recognition of intracellular mycobacteria, through MHC class II-dependent priming of T cellsChristopher R Singh, Pearl Bakhru, Arshad Khan, et al.
Nature Communications|April 14, 2016
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulatorMeng-Lei Zhu, Pearl Bakhru, Bridget Conley, et al.
Frontiers in Immunology|December 28, 2020
NOD2/RIG-I Activating <i>Inarigivir</i> Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceArshad Khan, Vipul K Singh, Abhishek Mishra, et al.
NPJ Vaccines|August 10, 2019
An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in miceArshad Khan, Pearl Bakhru, Sankaralingam Saikolappan, et al.
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
JCI Insight|March 13, 2020
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityUgur Eskiocak, Wilson Guzman, Benjamin Wolf, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
Rapamycin-induced enhancement of vaccine efficacy in miceChinnaswamy Jagannath, Pearl Bakhru
The Journal of Clinical Investigation|March 22, 2016
Estrogen turns down "the AIRE"Pearl Bakhru, Maureen A Su
Cellular Immunology|January 4, 2014
BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9Pearl Bakhru, Natalie Sirisaengtaksin, Emily Soudani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
Cutting edge: Nicastrin and related components of γ-secretase generate a peptide epitope facilitating immune recognition of intracellular mycobacteria, through MHC class II-dependent priming of T cellsChristopher R Singh, Pearl Bakhru, Arshad Khan, et al.
Nature Communications|April 14, 2016
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulatorMeng-Lei Zhu, Pearl Bakhru, Bridget Conley, et al.
Frontiers in Immunology|December 28, 2020
NOD2/RIG-I Activating <i>Inarigivir</i> Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceArshad Khan, Vipul K Singh, Abhishek Mishra, et al.
NPJ Vaccines|August 10, 2019
An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in miceArshad Khan, Pearl Bakhru, Sankaralingam Saikolappan, et al.
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
JCI Insight|March 13, 2020
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityUgur Eskiocak, Wilson Guzman, Benjamin Wolf, et al.
Pageof 1